This HTML5 document contains 44 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB02057/identifier/pubchem-compound/
n19http://linked.opendata.cz/resource/mesh/concept/
n8http://linked.opendata.cz/resource/drugbank/drug/DB02057/identifier/pubchem-substance/
n11http://linked.opendata.cz/resource/drugbank/drug/DB02057/identifier/drugbank/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n15http://linked.opendata.cz/resource/drugbank/drug/DB02057/identifier/chemspider/
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n14http://linked.opendata.cz/resource/drugbank/drug/DB02057/identifier/chebi/
owlhttp://www.w3.org/2002/07/owl#
n18http://linked.opendata.cz/ontology/mesh/
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n17http://linked.opendata.cz/resource/drugbank/drug/DB02057/identifier/wikipedia/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB02057/identifier/kegg-compound/
n9http://linked.opendata.cz/resource/drugbank/drug/DB02057/identifier/pdb/

Statements

Subject Item
n2:DB02057
rdf:type
n3:Drug
n3:description
AMPA is a specific agonist for the AMPA receptor.
n3:group
experimental
owl:sameAs
n6:DB02057 n12:DB02057
dcterms:title
AMPA
adms:identifier
n8:46505942 n9:AMQ n10:158397 n11:DB02057 n13:C11033 n14:28812 n15:1184 n17:AMPA
n3:synonym
1-Aminomethylphosphonic acid
n3:synthesisReference
Wilfried Lubisch, Berthold Behl, Hans-Peter Hofmann, Laszlo Szabo, "Pyrrolyl quinoxalindiones their production and use as AMPA receptor antagonists." U.S. Patent US6277850, issued June, 1996.
n18:hasConcept
n19:M0027584
n3:IUPAC-Name
n4:271B60A0-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B60A6-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B60A5-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B60A2-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B60A3-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B60A4-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B609E-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B609C-363D-11E5-9242-09173F13E4C5 n4:271B609F-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B609D-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B60AC-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B60AD-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B60A7-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B60A8-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B60AA-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B60A9-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B60AB-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
1066-51-9
n3:Bioavailability
n4:271B60B2-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B60B4-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B60B5-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B60B1-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B60B0-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B60B3-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B60A1-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B60AE-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B60AF-363D-11E5-9242-09173F13E4C5